The biochemical pharmacology of nogalamycin and its derivatives
- PMID: 1838416
- DOI: 10.1016/0163-7258(91)90080-6
The biochemical pharmacology of nogalamycin and its derivatives
Abstract
This review assimilates up-to-date information on the biochemical pharmacology of nogalamycin and selected derivatives that have shown good biological activities and/or received a relatively detailed investigation. The structure and chemical preparation of these derivatives from nogalamycin is described and the nomenclature which has been rather perplexing in the literature is clarified. The interaction of this class of compounds, particularly nogalamycin, with DNA is extensively reviewed. The biochemical mechanism of action of nogalamycin and its structurally closely-related derivatives is described. Among nogalamycin derivatives, menogaril showed distinct biochemical effects as well as superior cytotoxicity and antitumor activity and also proved to be effective against breast cancer clinically.
Similar articles
-
Menogaril: a new anthracycline agent entering clinical trials.Invest New Drugs. 1984;2(4):359-67. doi: 10.1007/BF00171586. Invest New Drugs. 1984. PMID: 6239835 Clinical Trial.
-
Activity of intravenous menogaril in patients with previously untreated metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study.Invest New Drugs. 1990 Aug;8(3):283-7. doi: 10.1007/BF00171838. Invest New Drugs. 1990. PMID: 2148741
-
Menogaril, an anthracycline compound with a novel mechanism of action: cellular pharmacology.Jpn J Cancer Res. 1990 Aug;81(8):842-9. doi: 10.1111/j.1349-7006.1990.tb02654.x. Jpn J Cancer Res. 1990. PMID: 2144516 Free PMC article.
-
New anticancer agents.Cancer Chemother Biol Response Modif. 1988;10:85-116. Cancer Chemother Biol Response Modif. 1988. PMID: 2484323 Review. No abstract available.
-
Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.J Clin Pharmacol. 1986 Sep-Oct;26(7):491-509. doi: 10.1002/j.1552-4604.1986.tb02942.x. J Clin Pharmacol. 1986. PMID: 2944917 Review.
Cited by
-
Divergent non-heme iron enzymes in the nogalamycin biosynthetic pathway.Proc Natl Acad Sci U S A. 2016 May 10;113(19):5251-6. doi: 10.1073/pnas.1525034113. Epub 2016 Apr 25. Proc Natl Acad Sci U S A. 2016. PMID: 27114534 Free PMC article.
-
The snogI Gene is Necessary for the Proper Functioning of the Nogalamycin Biosynthesis Pathway.Indian J Microbiol. 2021 Dec;61(4):467-474. doi: 10.1007/s12088-021-00941-7. Epub 2021 May 7. Indian J Microbiol. 2021. PMID: 34744202 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources